Pharma BD Deal Intelligence
Sigma-Tau Group / Enzon Pharmaceuticals (Specialty Pharma business)
2009 · Acquisition/Merger · $327M · Complete
Announcement Sentiment
75
Strongly positive
$300M cash + up to $27M milestones + 5-10% royalties on incremental sales. Oncaspar, Adagen, DepoCyt, Abelcet. Source: Enzon filings, Pharma Times, C&EN.
Key facts
- Announced Nov 09, 2009
- Deal value $327M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals